Microsoft PowerPoint - L00 Introduction

Previous Page

Next Page

Page Background

Meta-analysis - reduction in risk of disease recurrence

(25%) with adjuvant chemotherapy compared to

observation (

HR=0.75,

CI: 0.68-0.83).

Only 1/21 trials received

preoperative CRT

Only 2/21 received SCPRT